Abstract | Unlike other immune cells, B cells express both an antigen-specific B cell receptor (BCR) and Toll-like receptors (TLRs). Dual BCR and TLR engagement can fine-tune functional B cell responses, directly linking cell-intrinsic innate and adaptive immune programmes. Although most data regarding B cell-specific functions of the TLR signalling pathway have been obtained in mice, the discovery of patients with a deficiency in this pathway has recently provided an insight into human B cell responses. Here, we highlight the importance of the integration of signalling pathways downstream of BCRs and TLRs in modulating B cell function, focusing when possible on B cell-intrinsic roles.
Over the last decade, the unexpected success of B cell depletion therapies in treating human autoimmunity, combined with a growing recognition of the importance of neutralizing antibody responses in host defence, has led to an increased focus on understanding the role(s) of B cells in human immune function. B cells do not merely produce immunoglobulins; they can also secrete cytokines and serve as antigen-presenting cells, and therefore B cells have a multifaceted involvement in distinct immune responses.
A striking characteristic of B cells is the expression of a clonally rearranged, antigen-specific B cell receptor (BCR) in conjunction with the expression of one or more members of a family of germline-encoded receptors termed Toll-like receptors (TLRs), which are capable of recognizing discrete microbial ligands. This dual expression pattern permits B cells to uniquely integrate both antigen-specific signals and 'danger' signals via these key receptor systems. Although B cell development and survival both appear phenotypically unperturbed in the absence of TLR signals 1 , patients with a deficiency in a TLR signalling molecule -either myeloid differentiation primary-response protein 88 (MYD88) or IL-1R-associated kinase 4 (IRAK4) -possess an altered BCR repertoire with an increased proportion of autoreactive B cells, presumably owing to alterations in B cell selection processes 2 . Different B cell subsets exhibit variations in TLR expression patterns, and signalling via TLRs can modify B cell responses such as antibody production, antigen presentation and cytokine secretion. Therefore, individual TLR expression profiles permit various effector B cell populations to manifest specific response profiles following TLR engagement 3, 4 .
Notably, based on their functional responses as well as their BCR repertoire, naive mature B cell populations have been defined as either innate-like cells or adaptive cells
. Innate-like B-1 cells and marginal zone B cells generate rapid antibody responses independently of T cell help. By contrast, adaptive follicular B cells primarily participate in T cell-dependent (referred to as T-dependent throughout this article) responses that lead to the generation of high-affinity antibodies and long-term memory. Importantly, the expression of distinct profiles of TLRs and specific BCR profiles probably helps to specify the differentiation and function of these key innate-like versus adaptive B cell populations. During T-independent immune responses, dual BCR and TLR signalling rapidly induces marginal zone B cell and B-1 cell migration and antibody production. In addition, following the triggering of T-dependent immune responses, TLR responsiveness is directly modulated in activated follicular B cells, thereby affecting germinal centre responses. TLR engagement, in conjunction with BCR ligation, also provides a bridge between the innate and adaptive immune systems that may have an impact on antigen presentation, primary antibody responses, class-switch recombination (CSR) and subsequent memory responses.
All TLRs, with the exception of TLR3, require the signalling adaptor MYD88 to mediate activation signals, although TLR4 is unique in that it can signal through both the MYD88-dependent and the MYD88-independent pathway 5 . Therefore, analyses of animal models and humans with deficient function of this adaptor have begun to provide important new insights into how signals via TLRs affect B cell function and immune responses.
B-1 cells
IgM hi IgD low MAC1 + B220 low CD23 -cells that are dominant in the peritoneal and pleural cavities. The size of the B-1 cell population is kept constant owing to the self-renewing capacity of these cells. B-1 cells recognize self components, as well as common bacterial antigens, and they secrete antibodies that tend to have low affinity and broad specificity.
Marginal zone B cells
Mature B cells that are enriched mainly in the spleen marginal zone, which is located at the border of the white pulp.
Follicular B cells
A recirculating mature B cell subset that populates the follicles of the spleen and lymph nodes.
Germinal centre
A lymphoid structure that arises in follicles after immunization with, or exposure to, a T-dependent antigen. This structure is specialized for facilitating the development of high-affinity, long-lived plasma cells and memory B cells.
Class-switch recombination
(CSR). The process by which a heavy-chain variable-region gene segment that is attached to one heavy-chain constantregion gene segment in the expressed heavy-chain gene is recombined with a downstream constant-region gene segment, leading to the expression of a new antibody class.
Furthermore, recent work indicates that MYD88 also orchestrates B cell-activating factor (BAFF)-dependent signals through TACI (transmembrane activator and CAML interactor; also known as TNFRSF13B).
BAFF and the related cytokine APRIL (a proliferationinducing ligand) have a major role in peripheral B cell homeostasis and survival 6 . These cytokines bind to a family of receptors expressed primarily on B cells, including the BAFF receptor (BAFFR), B cell maturation antigen (BCMA) and TACI. BAFF levels are modulated by a complex interplay of factors, which include the number of B cells competing for ligand; the relative level of BAFF-binding receptors on specific B cell subsets; and pro-inflammatory (including TLR-driven) signals that modulate BAFF production by myeloid and/or stromal cell populations. BAFF-or BAFFR-deficient mice have severely decreased numbers of B cells, whereas overexpression of BAFF increases B cell numbers and promotes systemic lupus erythematosus (SLE)-like disease. Both BCR-mediated and TLR-mediated stimulation of mouse marginal zone B cells 7, 8 or B-1 cells 9 upregulates the expression of BAFFR and TACI, and thus increases the sensitivity of these cells to BAFF and APRIL. As a result, B cell activation during immune responses directly modulates the outcome of BAFF signalling by regulating the expression of BAFF family receptors. Finally, an additional level of control is provided through the direct participation of MYD88 in BAFF-triggered TACI signalling. This dual role for MYD88 in TLR and TACI signalling permits the precise regulation of peripheral B cell responses to infectious challenge and other microenvironmental cues.
This Review focuses on the role of dual BCR and TLR signalling (as well as other MYD88-dependent signals) in normal and dysregulated B cell immune function, with a particular emphasis on B cell-intrinsic events. We first summarize the specific roles for MYD88 in T-independent versus T-dependent B cell immune responses. We highlight work that demonstrates a non-redundant role for B cell-intrinsic MYD88 signals in antiviral immune responses, describe how MYD88 controls a B cell-intrinsic, TLR-independent pathway for immunoglobulin diversification, and review new information (gained from the analysis of patients with MYD88 or IRAK4 deficiencies) regarding the role for TLR signals in human immune function. Next, we describe how dual BCR and TLR signals may potentiate the risk for autoimmunity and discuss recent findings regarding how regulatory B cell function also requires TLR-MYD88 signals. Finally, we discuss emerging data indicating that dysregulated TLR and BCR signals collaborate during the development of B cell malignancies and, possibly, in other pathogenic B cell states.
T-independent B cell immune responses
As innate-like cells, B-1 and marginal zone B cells are the main players during T-independent immune responses. Innate-like B cells rapidly develop into IgM-producing plasmablasts during the early primary immune response 10 , and the importance of these subsets in T-independent responses to encapsulated bacteria has been demonstrated in models of infection, most notably with Streptococcus pneumoniae 11 . Both mice and humans with deficiencies in B-1 and marginal zone B cellsincluding patients with hypogammaglobulinemia, agammaglobulinemia 12 or Wiskott-Aldrich syndrome 13 -also exhibit increased susceptibility to infections with encapsulated bacteria. In addition, young children (who lack marginal zone B cells because the formation of this compartment is physiologically delayed until about 2 years of age), as well as splenectomized individuals, are at very high risk for such infections 14 .
In vitro analyses of TLR-modulated T-independent responses. Stimulation of B cells via TLR ligands has been used extensively as an in vitro model of T-independent immune responses. In vitro, both B-1 and marginal zone B cells rapidly proliferate and secrete antibodies in response to the engagement of TLRs, including TLR1-TLR2, TLR4, TLR6, TLR7 and TLR9 (REFS 3, (15) (16) (17) (18) . Interestingly, B-1 cells (predominantly B-1b cells; see BOX 1) stimulated in this manner secrete large amounts of IgA, whereas marginal zone B cells primarily produce IgM 4, 15 ; these features correlate with their in vivo functional roles against mucosal and blood-borne infections, respectively. Notably, both B-1 and marginal zone B cells exhibit stronger functional responses to TLR ligands than follicular B cells, as measured by the upregulation of activation markers 15, 18 and the production of interleukin-10 (IL-10) 19, 20 . Marginal zone B cells have also been shown to exhibit a greater potential to act as antigen-presenting cells than follicular B cells in 109 . Follicular B cells are the main players during T-dependent immune responses and belong to the adaptive arm of the immune system. They generate a clonally rearranged antigen-specific B cell receptor (BCR) and form memory responses that are dependent on T cell help. By contrast, B-1 and marginal zone B cells are usually considered to be innate-like immune cells and generate rapid but lower affinity antibody responses that are independent of T cell help.
The term 'B-1' refers to the idea that this population develops earlier during ontogeny than conventional B-2 cells 110 (see below). B-1 cells are enriched in the peritoneal and pleural cavities but can also be found in the spleen. CD5 expression further subdivides mouse B-1 cells into CD5 + B-1a and CD5 -B-1b cells. Recently, a B-1 cell progenitor was identified in the bone marrow of adult mice 111 . The term 'B-2' has traditionally been used to describe the main population of mature B cells that develop from common bone marrow precursors and are located in the bone marrow, spleen and lymph nodes. B-2 cells therefore include both follicular and marginal zone subsets, which currently are referred to as separate populations because of their distinct phenotypical and functional characteristics.
Recent work has defined a B cell subset in human peripheral blood with functional responses similar to those of mouse B-1 cells 112 . response to TLR stimulation 18 , allowing this unique subset to efficiently bridge T-independent and T-dependent responses by shuttling antigens from the marginal zone and presenting them in the T cell zones (FIG. 1b) .
Our group has investigated the mechanism(s) accounting for the differential responsiveness of adaptive (follicular) and innate-like (marginal zone) B cells to the TLR4 ligand lipopolysaccharide (LPS) 3 , which is a classical T-independent type 1 (polyclonal) stimulus. We confirmed an increase in cell cycle entry (proliferation) in marginal zone compared with follicular B cells in response to LPS, but could not identify significant differences in proximal TLR-driven biochemical signalling events, such as the activation of the nuclear factor-κB (NF-κB) and mammalian target of rapamycin (mTOR) pathways. Notably, follicular B cells had reduced basal and inducible levels of the cell cycle and growth regulator MYC. Consistent with a key role for MYC in modulating LPS responsiveness, enforced expression of MYC in follicular B cells eliminated the delay in cell cycle entry and promoted increased immune responses that mimicked the functional responses of marginal zone B cells. In vivo analyses of TLR-modulated T-independent responses. Signalling via both MYD88 and Bruton's tyrosine kinase (BTK; a kinase essential for BCR signalling) is required for T-independent pathogen-specific IgM production in a mouse model of Borrelia hermsii infection 21 . Mice deficient in both BTK and MYD88 failed to generate pathogen-specific IgM 21 , whereas mice deficient in BTK alone generated specific antibodies and resolved bacteraemia, but with delayed kinetics compared with wild-type mice. Mice deficient in TLR1, TLR2 or MYD88 generated pathogen-specific antibodies with delayed kinetics and suffered more severe episodes of bacteraemia compared with control mice, suggesting that MYD88 synergizes with BCR signals and that, in Btk -/-B cells, TLR-mediated stimulation is required to rescue the defective BCR signal.
Two groups have analysed in vivo B cell responses to Salmonella enterica subsp. enterica serovar Typhimurium in the setting of a MYD88 deficiency restricted to the B cell compartment 22, 23 . S. Typhimurium induces both T-independent and T-dependent immune responses. Following S. Typhimurium infection, S. Typhimuriumspecific IgM and IgG levels were initially lower in mice with Myd88 -/-B cells than in control mice, but no difference was observed at later time points (>4 weeks) after infection. Moreover, MYD88 signalling in B cells markedly inhibited both neutrophil and natural killer (NK) cell responses to S. Typhimurium 23 . Based on these limited in vivo data, MYD88 signalling in B cells in conjunction with BCR engagement appears to have an important role during early T-independent immune responses to bacteria, leading to the rapid production of protective IgM and IgG, as well as the modulation of other innate effector cell populations (presumably via cytokine and/or chemokine production).
TLR signals in innate-like B cell positioning. TLR signals have an important role in the regulation of the localization and migration of B-1 and marginal zone B cells (FIG. 1a) . Although they are enriched in the splenic marginal zone, marginal zone B cells continuously circulate between the marginal zone and the splenic follicles, a property that allows this population to capture and shuttle blood-borne antigens to follicular dendritic cells. In vivo treatment with LPS promotes near-complete relocalization of marginal zone B cells into the splenic white pulp [24] [25] [26] . Sphingosine-1-phosphate receptor 1 (S1PR1; also known as S1P 1 ) is an important regulator of marginal zone B cell retention, and blocking S1PR1 with the inhibitor FTY720 in vivo leads to the migration of marginal zone B cells into follicles 27 . Interestingly, LPS administration results in the downregulation of S1PR1 expression by marginal zone B cells, and thus reduces the chemotactic responsiveness of these cells to S1P, possibly explaining the effect of LPS on B cell localization. Of note, TLR2, TLR3 and TLR7 ligands also promote marginal zone B cell migration 28 . However, whereas in vivo treatment with TLR2, TLR4 and TLR7 ligands resulted in the downregulation of S1pr1 mRNA levels, no change was seen after stimulation via TLR3, implying that at least two distinct TLR-dependent signalling pathways can promote the migration of marginal zone B cells.
Similarly, B-1 cells express very high levels of integrins, and stimulation via TLRs induces a massive egress of B-1 cells from the peritoneal cavity that is associated with the coordinated downregulation of integrin and CD9 expression 29 . Thus, B cell-intrinsic TLR signalling in vivo can directly alter B-1 cell responsiveness, thereby directing the migration of these cells to sites where rapid local antibody responses help to limit pathogen growth. This probably also allows innate-like B cells to modulate the local effector functions of other immune cell types.
MYD88 signals in human innate-like B cell responses.
Although it is difficult to judge how findings generated using mouse models can be translated into the human system, some insight into the role of B cell-intrinsic TLR signals can be obtained from the analysis of patients with inborn errors in one of the downstream TLR signalling effectors MYD88 and IRAK4 (REFS 30-32)
. In these patients, S. pneumoniae is the most common invasive pathogen, followed by Staphylococcus aureus and Pseudomonas aeruginosa -all of which trigger T-independent responses 31 . By contrast, antibody responses to protein antigens are normal in these patients, and no severe viral, parasitic or fungal diseases have been observed. The predominance of infections with encapsulated bacteria suggests that TLR signalling . Patients with these inborn errors are typically predisposed during infancy and early childhood to recurrent life-threatening bacterial infections, which most commonly involve invasive pneumococcal disease with only limited signs of systemic inflammation. Interestingly, no deaths or invasive infectious episodes have been reported in patients beyond 14 years of age. Moreover, no severe viral, parasitic or fungal diseases have been reported in these patients, and the range of bacterial pathogens that they are susceptible to seems to be restricted to Streptococcus pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus. Immune responses to protein antigens were also mainly normal. Treatment of these patients with prophylactic antibiotics, anti-pneumococcal vaccination and/or intravenous immunoglobulins seems to have a beneficial impact on the disease. The absence of severe infections in older patients may result from maturation of other signalling cascades and/or adaptive immune function that gradually compensates for the lack of TLR signalling.
Another group of inborn errors have been shown to affect the induction of interferon-β (IFNβ) and IFNλ in response to TLR3 signalling (which is independent of MYD88) or in response to TLR7, TLR8 and/or TLR9 signalling. These disorders are caused by an autosomal recessive deficiency of UNC93B (an endoplasmic reticulum-resident transmembrane protein deficiency that affects TLR3, TLR7, TLR8 and TLR9) 114 and autosomal dominant TLR3 deficiency 115 . Both deficiencies are associated with the occurrence of herpes simplex virus-mediated encephalitis.
Overall, these data suggest that deficits in TLR signalling increase the susceptibility of the host to specific pathogens without obviously affecting immune responses to T-dependent immunization or immune cell development. However, further studies are required to fully understand the precise contributions of TLRs and IL-1R to human host defence. Nature Reviews | Immunology 34, 35 . In summary, MYD88 signalling in B cells is crucial for T-independent B cell responses, as these signals activate and position B cells, thereby promoting rapid and appropriately localized production of pathogenspecific antibodies. In addition, B cell-intrinsic MYD88 signals triggered by TACI appear to promote extrafollicular CSR, facilitating improved primary protective T-independent antibody responses. (FIG. 2) . In vitro, follicular B cells proliferate, produce cytokines and secrete antibodies following stimulation by various μMT mice These mice carry a stop codon in the first membrane exon of the immunoglobulin μ-chain constant region. They lack IgM + B cells, and B cell development is arrested before the differentiation stage at which IgD can be expressed.
MYD88 signals in T-dependent B cell responses
B cells are recruited into T-dependent immune responses primarily from the follicular subset, after which they enter a germinal centre and differentiate into either antibody-secreting plasma cells or memory B cells. Although innate-like B cells generally display stronger responses to TLR engagement alone, antigen-mediated follicular B cell responses can be modulated by simultaneous BCR and TLR engagement
Ribi adjuvant
An emulsion containing a metabolizable oil, a detergent and bacterial products, including the TLR4 ligand monophosphoryl lipid A.
Hapten
A molecule that can bind to antibodies but cannot by itself elicit an immune response. Antibodies that are specific for a hapten can be generated when the hapten is chemically linked to a protein carrier that can elicit a T cell response. . Purification of mouse germinal centre B cells revealed an enhanced responsiveness of these cells to TLR ligands and increased expression of Myd88 mRNA compared with follicular B cells, suggesting that follicular B cells may become more sensitive to TLR engagement during the course of a T-dependent immune response 16 . In addition, TLR4 signalling in B cells has been proposed to increase their migration to lymph nodes and accumulation in germinal centre dark zones, perhaps helping to sustain ongoing germinal centre reactions 37 .
Virus-like particles
A role for TLRs in promoting plasma cell differentiation has been proposed. This is based on the finding that follicular B cells secrete immunoglobulins and express the differentiation factors B lymphocyte-induced maturation protein 1 (BLIMP1; also known as PRDM1) and X-boxbinding protein 1 spliced isoform (XBP1s) in response to TLR ligands, although in the absence of co-stimulation these responses were primarily elicited in B-1 and marginal zone B cells 15 . In humans, naive B cells are minimally responsive to TLR ligands, but memory B cells proliferate and differentiate into antibody-secreting plasma cells in response to CpG oligodeoxynucleotides (ODNs), which are ligands for TLR9 (REF. 38 ). These data led to the suggestion that the stimulation of human memory B cells through TLRs may contribute to the long-term maintenance of serological memory 38 . A later study showed that maximal activation of naive human B cells requires a combination of BCR engagement, T cell help via CD40 signalling and TLR stimulation 39 . B cell-intrinsic MYD88 signals in response to T-dependent antigens. Together, the above data suggest that, in both mice and humans, B cell-intrinsic TLR signals can promote events associated with T-dependent immune responses. This has led to significant interest in determining the in vivo role of MYD88 in B cells in the response to protein antigens. This question was first addressed by transferring either wild-type or MYD88-deficient B cells into μMT mice, which lack functional B cells, and analysing the response to intraperitoneal immunization with human serum albumin (HSA) and LPS co-adsorbed onto the adjuvant alum 40 . In this setting, the production of HSA-specific IgM and IgG1 antibodies was severely impaired in mice with MYD88-deficient B cells. Similar results were obtained after immunization with flagellin, and the authors provided evidence that MYD88 signalling promotes enhanced antigen presentation by B cells, as well as the differentiation of germinal centre B cells into plasma cells. This study concluded that the activation of TLR signalling in B cells is necessary for antibody responses to T-dependent antigens.
A subsequent study further tested this idea by immunizing wild-type mice and mice deficient in both MYD88 and TIR-domain-containing adaptor protein inducing IFNβ (TRIF) with trinitrophenol-haemocyanin (TNP-Hy) or trinitrophenol-keyhole limpet haemocyanin (TNP-KLH) as antigens in combination with various adjuvants 1 . TNP-specific antibody responses were largely intact in the double-deficient mice, although IgG2b and IgG2c titres were slightly lower than those of wild-type mice in response to TNP-KLH in Ribi adjuvant. In a third study, wild-type or MYD88-deficient B cells were transferred to μMT mice, which were then immunized with the antigen 4-hydroxy-3-nitrophenylacetyl-chicken γ-globulin (NP-CGG) in alum 16 . During both the primary immune response and the re-challenge with NP-CGG 4 months after initial immunization, NP-specific IgM and IgG levels in the recipients of MYD88-deficient B cells were the same as those in the recipients of wild-type B cells. However, the addition of LPS during the primary immunization greatly increased the antibody response to NP-CGG, and the increase in NP-specific IgM and IgG2a levels required MYD88 expression in B cells, whereas the increase in NP-specific total IgG levels did not. The ability of TLR signals to activate memory B cells was also tested in μMT mice that had received wild-type or MYD88-deficient B cells by injecting LPS several months after a series of NP-CGG immunizations. LPS induced a transient increase in both total and NP-specific IgM and IgG levels in recipients of wild-type B cells but not in recipients of MYD88-deficient B cells. Together, the last two studies support a model in which B cell MYD88 signalling is not required to generate T-dependent antigen-specific antibody responses, but such signals can augment early antibody production, influence CSR and promote the differentiation of memory B cells into plasma cells.
Several factors may help to explain the discrepancy in the results from these studies. The engagement of B cell TLRs might be required in settings where BCR engagement or perhaps T cell co-stimulation is limited. Thus, it is possible that the lower levels of BCR crosslinking mediated by HSA compared with TNP-KLH (or NP-CGG) may affect the requirement for MYD88 signals in B cells 41 . In addition, a comparison of responses to HSA with or without the hapten dinitrophenol (DNP) indicated that the antibody response to HSA with LPS requires MYD88 signalling, whereas DNP-HSA in incomplete Freund's adjuvant elicited equivalent responses in wild-type and Myd88
Trif
-/-mice. These findings led to the suggestion that haptenated antigens are inherently immunogenic and that this limits the requirement for MYD88 signals 42 . In addition to the variation in the antigens used in these studies, recent reports suggest that the physical form of TLR ligands has an important role during adaptive immune responses. Using either a myeloid cell-or B cell-specific deletion of Myd88, DeFranco and colleagues investigated how various forms of a TLR ligand influence T-dependent immune responses 43 . Ovalbumin-specific antibody responses to ovalbumin with soluble CpG ODNs, to ovalbumin with an aggregated form of CpG ODNs and to ovalbumin covalently linked to CpG ODNs were dependent on MYD88 expression in dendritic cells (DCs) but not B cells. By contrast, antigen-specific IgG responses to immunization with CpG ODNs incorporated in proteinaceous virus-like particles (VLPs) that were derived from bacteriophage Qβ depended largely on MYD88 expression in B cells but not DCs. Mice that lacked MYD88 in B cells were deficient in bacteriophage Qβ-specific Antinuclear antibodies (ANAs). Heterogeneous autoantibodies that are specific for one or more antigens present in the nucleus, including chromatin, nucleosomes and ribonuclear proteins. ANAs are found in association with many different autoimmune diseases.
Immune complexes
Complexes of antigen bound to antibody and, sometimes, components of the complement system. The levels of immune complexes are increased in many autoimmune disorders, in which they become deposited in tissues and cause tissue damage.
MRL-lpr mice
A mouse strain that spontaneously develops glomerulonephritis and other symptoms of systemic lupus erythematosus. The lpr mutation causes a defect in CD95 (also known as FAS), preventing apoptosis of activated lymphocytes. The MRL strain contributes disease-associated mutations that have yet to be identified.
MRL-gld mice
A mouse strain that has a naturally occurring mutation in CD95 ligand that causes a generalized lymphoproliferative disease, similar to that of MRL-lpr mice.
IgG2b and IgG2c antibodies, and this correlated with a dramatic defect in the differentiation of germinal centre B cells. Consistent with a crucial role for B cellintrinsic MYD88 signals in the humoral response to viruses, the influenza virus-specific IgG response generated following immunization with inactivated H1N1 influenza virus was substantially reduced in mice with MYD88-deficient B cells 43 . These data are consistent with the previous demonstration that VLPs containing the human papillomavirus 16 (HPV16) major capsid protein L1 can directly induce CSR in B cells in a manner dependent on intrinsic MYD88 expression 44 . In another study, μMT mice reconstituted with TLR9-deficient B cells and challenged with bacteriophage Qβ VLPs containing CpG ODNs had substantially lower VLP-specific IgG2a titres than recipients of wild-type B cells, further supporting a role for B cell-intrinsic MYD88 signalling in driving CSR 45 . Of note, major T-dependent immune deficits have not been identified in MYD88-or IRAK4-deficient patients; however, published data are largely limited to total IgG responses to robust T-dependent antigens (for example, tetanus toxoid-and diphtheria toxin-derived antigens) 31 .
MYD88-dependent T-dependent B cell responses in infection.
Studies involving the infection of mice with live pathogens have supported a role for MYD88 in modulating humoral immunity, although this role has not been shown to be B cell intrinsic in all cases. Both TLR7 and MYD88 were shown to be important for class switching to IgG2a/c in response to influenza virus infection 46 . Furthermore, although B cell-specific expression of MYD88 was dispensable for the early T-dependent antibody response to mouse polyoma virus infection, it was required for the maintenance of long-term antibody production 47 . A recent study examining the failure of respiratory syncytial virus (RSV) vaccines in infants concluded that insufficient TLR signalling in B cells resulted in the production of low-affinity, non-protective antibodies 48 . Moreover, infection with live RSV failed to elicit virus-specific IgG responses in μMT mice reconstituted with MYD88-deficient B cells 48 . These findings are not limited to viral infections; one report described a B cell-intrinsic role for MYD88 signalling in generating an appropriate primary T helper 1 (T H 1) cell response to S. enterica 36 . This study used mixed bone marrow chimaeras in which the B cell compartment was deficient in MYD88. At 1 week postinfection, T cells isolated from these chimeric mice exhibited deficient interferon-γ (IFNγ) and IL-10 secretion following challenge with an S. enterica antigen. Furthermore, using mixed bone marrow chimaeras in which B cells lacked expression of specific cytokines, the authors identified a supporting role for B cell-mediated secretion of IL-6 and IFNγ in the development of T H 17 and T H 1 responses, respectively 36 . Collectively, these data demonstrate that MYD88 signalling in B cells can make important contributions to T-dependent antibody responses, and the requirement for B cell MYD88 varies depending on the nature of the protein antigen and the TLR ligand. In particular, B cell-intrinsic MYD88 signalling appears be involved in: driving class switching to IgG2a (or its equivalent (IgG2c) in C57BL/6 mice) during primary T-dependent responses; promoting the differentiation of germinal centre and memory B cells into antibody-secreting plasma cells; and supporting effector T cell differentiation through cytokine secretion (FIG. 2) .
MYD88 and B cells in autoimmunity
Recent work demonstrates that MYD88 signals and, most notably, dual TLR and BCR engagement influence mechanisms of B cell tolerance (FIG. 3) . Furthermore, new data suggest that genetic changes that alter BCR and/ or TLR signalling thresholds probably promote these signalling events and that autoreactive B cells triggered in this way may directly break T cell tolerance, thereby facilitating germinal centre reactions that lead to the production of pathogenic autoantibodies.
Dual BCR and TLR activation in promoting B cellmediated autoimmunity. Despite a diverse range of potential autoantigens, many autoimmune diseases are characterized by a restricted autoantibody repertoire. In addition to recognizing pathogens, TLRs can recognize self ligands, in particular nuclear antigens that are released from apoptotic cells. Furthermore, dual TLR and BCR engagement in B cells has been implicated in the initial activation of autoreactive B cells, helping to explain the propensity of these cells to develop antinuclear antibodies (ANAs) [49] [50] [51] . The importance of dual BCR and TLR signalling in the activation of autoreactive B cells was initially demonstrated in vitro using B cells expressing the AM14 BCR, which is a low-affinity BCR specific for autologous IgG2a 52 . Stimulation of AM14 B cells with DNA-IgG2a or DNA-associated protein-IgG2a immune complexes resulted in B cell proliferation, whereas IgG2a immune complexes containing foreign protein, but no TLR ligand, did not. MYD88 signalling downstream of TLR9 was crucial for the activation of AM14 B cells, suggesting the involvement of dual BCR and TLR signals 52 . Similarly, immune complexes containing RNA or RNA-associated protein activated AM14 B cells via TLR7 (REF. 53 ). Furthermore, a crucial role for MYD88 signalling in the generation of RNA-and DNA-specific autoantibodies in vivo was demonstrated in MYD88-deficient MRL-lpr mice and MRL-gld mice. In contrast to littermate controls, these MYD88-deficient mice do not have detectable levels of ANAs, and they have markedly reduced levels of RNA-and DNA-specific autoantibodies and less severe glomerulonephritis 53, 54 . Two distinct mechanisms could explain the importance of MYD88-dependent signalling for autoantibody production in vivo in these autoimmune models. First, autoantibody production could be induced by direct B cell-intrinsic signals mediated by dual BCR and TLR activation or, second, this could be an indirect effect of TLR-and immune complex-mediated activation of plasmacytoid DCs, as the activation of these cells leads to increased type I IFN production, which has an important role in the pathogenesis of SLE 55 .
Nature Reviews | Immunology To date, the requirement for B cell-intrinsic MYD88 signals has been investigated in only a limited number of autoimmune models. Using a mixed bone marrow chimaera strategy, Groom et al. demonstrated that B cell-specific MYD88 deficiency decreases autoantibody production and the glomerular deposition of immunoglobulins and complement components in transgenic mice overexpressing BAFF, stressing the importance of B cell-intrinsic MYD88 signalling in BAFF-triggered autoimmunity 56 . The deletion of Myd88 also prevented class switching to pathogenic IgG2a and IgG2b in FcγRIIB (IgG Fc receptor IIB)-deficient B cells that expressed a DNA-specific BCR heavy chain, suggesting that the role of MYD88 is B cell intrinsic in this model 57 . Furthermore, our group recently characterized a model of autoimmunity in which B cells, but not other haematopoietic lineages, lack Wiskott-Aldrich syndrome protein (WASP) 49 . In the absence of WASP, peripheral B cells are mildly hyperresponsive to BCR and TLR ligands, and mice with WASP-deficient B cells develop SLE-like autoimmunity characterized by spontaneous germinal centre formation, the generation of pathogenic IgG2b and IgG2c autoantibodies, glomerulonephritis and early mortality. However, chimeric mice with B cells lacking both WASP and MYD88 fail to develop any autoantibodies or signs of autoimmune disease, demonstrating a crucial role for B cell-intrinsic MYD88 signalling in this model. Disease development also required wild-type T cells, which suggests that enhanced BCR and TLR signals are sufficient to drive a loss of T cell tolerance through B cell-intrinsic MYD88 signalling. However, in other models, type I IFNs derived from immune complex-activated plasma cytoid DCs may still have a dominant role in disease development.
The relative contribution of specific TLR signals to MYD88-dependent autoimmune disease has been addressed by several groups 50, 51 . Notably, TLR7 and TLR9 exhibit divergent roles in mouse autoimmune disease. Briefly, TLR7-deficient MRL-lpr mice 54 have decreased RNA-specific autoantibody titres but preserved autoimmune responses to double-stranded DNA (dsDNA) compared with control MRL-lpr mice. By contrast, TLR9-deficient MRL-lpr mice have markedly decreased levels of autoantibodies specific for dsDNA and chromatin, but elevated titres of autoantibodies specific for RNA and RNA-associated protein 58, 59 . Tlr7 -/-MRL-lpr mice are protected from immune complex-mediated glomerulonephritis, whereas glomerulonephritis and mortality are exacerbated in the absence of TLR9 (REFS 58, 60) . Although the events responsible for this TLR9-mediated protective Nature Reviews | Immunology effect remain unclear, it is interesting that the accelerated autoimmunity in Tlr9 -/-mice depends on intact TLR7 signalling 54, 60 . Importantly, whether TLR7 and TLR9 signalling influences autoimmunity in a B cell-intrinsic manner has not been addressed.
In addition, MYD88 signalling may affect autoimmunity independently of TLR7 and TLR9, via TACI signalling 33 or, alternatively, via its role in IL-1 or IL-18 signalling. TACI-deficient mice develop a spontaneous lymphoproliferative and autoimmune disease, and patients with common variable immune deficiency syndrome owing to TACI mutations exhibit a higher risk for autoimmunity 61 ; this suggests a protective role for TACI in autoimmunity. Overall, both B cell-intrinsic and B cell-extrinsic MYD88-dependent TLR signals are likely to promote autoimmune disease, with TLR7 and TLR9 having opposing roles. However, the B cellintrinsic roles of individual TLR signals in autoimmunity remain to be defined.
Roles for MYD88 signals in human autoimmunity.
Direct evidence for B cell-intrinsic MYD88 signalling in the pathogenesis of human autoimmune disease is lacking. However, genome-wide association studies have implicated genetic polymorphisms that affect TLR signalling pathways in susceptibility to SLE. Notable among these are mutations in IFN-regulatory factor 5 (IRF5) 62 -which encodes a transcription factor involved in the production of IFNα following TLR ligation -and in IRAK1 (REF. 63 ). Two proteins involved in ubiquitinmediated downregulation of NF-κB signalling -namely, TNF-induced protein 3 (TNFAIP3; also known as A20) and its binding partner TNFAIP3-interacting protein 1 (TNIP1; also known as ABIN1) -have also been associated with human SLE, and this might implicate TLRmediated NF-κB activation in disease pathogenesis 64, 65 . B cells from mice with a B cell-specific Tnfaip3 deletion 66 or from mice with mutant TNIP1 that is unable to bind polyubiquitin (owing to a D485N substitution) 67 have enhanced TLR-mediated NF-κB activation, and both groups of mice develop lupus-like systemic autoimmunity. Disease development in Tnip1 D485N mice was shown to be MYD88 dependent, which implicates TLR-mediated NF-κB activation in the pathogenesis of human SLE. Although not validated via genomewide association studies, candidate-gene approaches have suggested associations between TLR7 or TLR9 polymorphisms and autoimmune disease [68] [69] [70] . Interestingly, despite the role for TLR-MYD88 signalling in the activation of autoreactive B cells, an unanticipated increase in autoreactive naive B cells was observed in patients with MYD88 or IRAK4 deficiency 2 . A high number of immature B cells from these patients express BCRs that bind to nuclear antigens, and the deletion of these autoreactive B cells before entry into the mature peripheral compartment is defective. Together, these data suggest that the normal mechanisms of central and peripheral B cell tolerance may depend on intact MYD88 signalling. However, despite the increase in autoreactive B cells, patients with MYD88 or IRAK4 mutations do not have increased serum ANA titres, which is perhaps consistent with a requirement for MYD88 also in the activation of such autoreactive B cells.
MYD88 signals in regulatory B cell function
Functional and phenotypical definitions of regulatory B cells. Although B cell-intrinsic TLR signals can potentially break tolerance and trigger autoimmune disease, these same signals also have a role in the function of regulatory B cells, which help to suppress immune responses and maintain self-tolerance (FIG. 4) 75, 76 and B10 B cells 74 , respectively. As IL-10 production can be triggered by a variety of stimuli, it remains unlikely that these cells comprise a distinct B cell developmental subset. Also, although not discussed here, B cells may also use transforming growth factor-β (TGFβ) secretion to exert their regulatory activity 77, 78 .
T regulatory type 1 cells
A subset of CD4 + regulatory T cells that secrete high levels of IL-10 and that downregulate T H 1 and T H 2 cell responses in vitro and in vivo through one or more contact-independent mechanisms that are mediated by the secretion of soluble IL-10 and TGFβ1.
The importance of IL-10-producing B cells has been demonstrated in a range of mouse models of auto immune diseases, including inflammatory bowel disease 75 , collagen-induced arthritis 73 , experimental auto immune encephalomyelitis (EAE) 79 and SLE 20 . Additional data indicate a regulatory function for B cells in models of infection with Leishmania major 80 , Schistosoma mansoni 81 , Brugia pahangi 82 , S. Typhimurium 23 and Helicobacter pylori 83 .
Roles for TLR signals in modulating regulatory B cell activity. Intrinsic TLR stimulation appears to be crucial for modulating the activity of IL-10-producing B cells, predominantly by promoting their differentiation and clonal expansion. In vitro, stimulation of mouse splenic B cells through TLR9 results in high levels of IL-10 production and, interestingly, the amount of IL-10 is substantially higher in B cells from lupus-prone mice than in B cells from wild-type mice 84 . In splenic marginal zone and marginal zone precursor B cells, IL-10 production can be triggered by TLR4 or TLR9 engagement 20 . TLR4 ligation, as well as polyclonal B cell stimulation, induced cytoplasmic IL-10 expression and rapid clonal expansion of splenic CD1d hi CD5 + B cells 74 . Although the development of IL-10-producing CD1d hi CD5 + B cells was normal in Myd88 -/-mice, direct LPS-induced IL-10 production and secretion were markedly reduced. In a mouse model of EAE, B cell-intrinsic TLR signals resulted in the suppression of both T H 1 cell-mediated and T H 17 cell-mediated inflammatory responses and facilitated recovery from disease 85 . The MYD88-dependent production of IL-10 by B cells can also modulate the response to infectious challenge. For example, B cells exert a regulatory function during S. Typhimurium infection that requires B cell-intrinsic MYD88 signalling and IL-10 secretion 23 . MYD88-deficient mice infected intravenously with virulent S. Typhimurium exhibit increased mortality, whereas mice with a B cell-specific MYD88 deficiency exhibit prolonged survival. Notably, B cellintrinsic MYD88 signals appear to drive two distinct programmes in this setting. Mice with Myd88 -/-B cells have lower basal levels of total and S. Typhimurium-specific natural IgM and delayed S. Typhimurium-specific IgM and IgG responses after infection, indicating that MYD88 signals accelerate humoral immunity. By contrast, bone marrow chimaeras with a B cellrestricted IL-10 deficiency exhibit increased survival after S. Typhimurium infection 23 , suggesting that B cell-derived IL-10 limits immune responses to S. Typhimurium.
In a model of H. pylori-induced gastric immunopathology, infection activates B cells in a MYD88-and TLR2-dependent manner 83 . Activated B cells subsequently promote IL-10 production by CD4 + CD25 + T regulatory type 1 cells in vitro and in vivo, and this suppresses excessive H. pylori-associated gastric pathology. In contrast to the S. Typhimurium infection model, however, these events do not require B cell-intrinsic IL-10 expression.
IL-10-producing B cells with a regulatory function have also been identified in humans by two independent groups 86, 87 . IL-10 expression was identified in B cells derived from the peripheral blood, spleen and tonsils following stimulation either by LPS or by CpG DNA plus CD40 ligation 86, 87 . Notably, suppressive function and IL-10 production were impaired in peripheral B cells derived from patients with SLE 87 . In summary, B cells with regulatory function differentiate and exert their suppressor function mainly through IL-10 production following TLR signalling. So far, most data have been obtained from mouse studies, and the importance of MYD88 signals in initiating suppressive B cell function has been demonstrated in at least two models of infection. Additional studies are required to determine whether MYD88 signalling is required for the generation or function of IL-10-producing B cells in humans.
MYD88 in additional pathogenic B cell responses
Roles for BCR and MYD88 signals in B lymphoid malignancies. Approximately 90% of human lymphomas arise from B cells, and diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Several distinct DLBCL subtypes have been defined based on genetic signatures that reflect their putative origins; one such subtype is activated B cell-like (ABC) DLBCL, which is treatment resistant and has a poor prognosis 88 . ABC DLBCL probably originates from the early stages of a germinal centre reaction and this tumour type is characterized by high-level constitutive activation of NF-κB 89 and coordinate high-level expression of protein kinase Cβ (PKCβ), which is the BCR-dependent upstream activator of the NF-κB signalling cascade 90, 91 . RNA interference screens of ABC DLBCL tumours identified the importance of the CARD11-BCL-10-MALT1 complex downstream of the BCR-PKCβ pathway in driving NF-κB activation 92 . Consistent with this, somatic mutations in the genes encoding the scaffold protein CARD11 (caspase recruitment domaincontaining protein 11; also known as CARMA1) 93 and the BCR-associated signalling effector molecules CD79a and CD79b 94 are present in ~10% and 20% of ABC DLBCL tumours, respectively. Recently, MYD88 mutations have also been identified in 39% of ABC DLBCL tumours, thereby also implicating TLR-mediated activation of NF-κB in lymphomagenesis 95 . Strikingly, a single substitution (L256P) within the Toll/IL-1-receptor (TIR) domain of MYD88 accounted for most of these mutations. L256P MYD88 was noted to be a gain-of-function mutant that spontaneously forms a signalling complex with IRAK1 and IRAK4, and thus causes enhanced NF-κB activation. Interestingly, L256P MYD88 also activated signalling through the JAK-STAT3 (Janus kinase-signal transducer and activator of transcription 3) pathway, resulting in enhanced production of IL-6 and IL-10, which probably promotes autocrine survival signals 96, 97 . Most remarkably, MYD88 mutations were noted in ABC DLBCL tumours that also contained CARD11 or CD79A and CD79B mutations that affect BCR signalling 95 . Thus, in a manner analogous to both virus-driven B cell activation and B cell-intrinsic autoimmunity, dual BCR and TLR signals appear to promote the survival of a subset of refractory B cell lymphomas. Finally, MYD88 mutations are not limited to ABC DLBCL tumours. The same L256P mutation was also observed in 9% of gastric mucosa-associated lymphoid tissue lymphomas and 3% of chronic lymphocytic leukaemias 98 , highlighting the importance of dysregulated TLR signalling in B cell-derived malignancies.
B cell MYD88 signals in atherosclerosis. Atherosclerosis is a chronic inflammatory disease that is affected by TLR responses. TLRs, in particular TLR4, can be activated by endogenous oxidized lipid epitopes, and apolipoprotein E-deficient mice (Apoe -/-mice) that lack expression of MYD88 or TLR4 have lower levels of atherosclerosis than Apoe -/-control mice 99, 100 . Furthermore, a human D299G TLR4 polymorphism, which decreases TLR4 signalling, is associated with a decreased risk of atherosclerosis 101 . 104 . Furthermore, B cell depletion with a CD20-specific antibody decreases the development of atherosclerosis in the Ldlr -/-and Apoe -/-mouse models of atherosclerosis 105, 106 , and protection correlates with a decline in oxidized low density lipoprotein (oxLDL)-specific IgG titres and coordinate preservation of oxLDL-specific IgM titres 106 . Patients with SLE have a markedly increased risk of athero sclerotic cardiovascular disease 107 , and those with a history of cardio vascular events have elevated titres of IgG antibodies specific for oxLDL and malondialdehydemodified LDL compared with other SLE patients or population controls 108 , suggesting that these autoantibodies may promote atherogenesis.
Although not yet directly addressed, it will be interesting to determine whether TLR-MYD88 signalling in B cells promotes accelerated atherosclerosis in animal models and patients with autoimmune disease, given the role of B cell-intrinsic MYD88 signals in the pathogenesis of autoimmunity.
Conclusions and future perspectives B cell-intrinsic MYD88 signals and, most notably, the integration of dual TLR and BCR signals have a crucial role in B cell responses to pathogen challenge. This unique functional programme is crucial for protective immune responses to specific viruses and probably also for responses to encapsulated bacteria. Strikingly, new findings suggest that this hardwired programme also predisposes to pathogenic B cell responses, including humoral autoimmunity and B cell malignancies. Key open questions include how developmental eventsas well as local microenvironmental and inflammatory cues (or other cellular stimuli) -function to specifically modulate this signalling programme and, most importantly, whether it will be possible to manipulate such signals to develop novel immunization strategies. Finally, although most of our knowledge to date is derived from mouse studies, it will be important to progressively extend our investigations to human B cells to determine ways to optimally leverage or curtail these responses for translational applications.
